Outcomes

The available evidence for GHRP-6 outcomes comes entirely from preclinical animal studies, with no human clinical trial data currently available. The reported results span several therapeutic areas but are limited by the lack of clinical validation.

Cardiovascular Effects

One study reported that GHRP-6 improved post-infarct ventricular remodeling and systolic dysfunction in a permanent coronary ligation model. However, specific quantitative outcomes (such as ejection fraction improvements or infarct size reduction) are not detailed in the available abstracts.

Pulmonary/Respiratory Effects

GHRP-6 demonstrated protective effects against acute lung injury and its progression to interstitial fibrosis in animal models. The compound appeared to ameliorate both the acute inflammatory response and subsequent fibrotic changes, though specific biomarker values or functional improvements are not specified.

Cognitive/Neurological Effects

When co-administered with EGF (epidermal growth factor), GHRP-6 showed potential in attenuating cognitive decline in preclinical models. The study reported both behavioral improvements and molecular evidence of benefit, but specific cognitive test scores or biomarker changes are not provided in the abstract.

Renal Effects

GHRP-6 formulated as a hydrogel showed therapeutic potential for acute kidney injury through metabolic regulation mechanisms. The specific renal function parameters or recovery metrics are not detailed in the available information.

Reproductive/Pregnancy-Related Effects

Research involving the ghrelin/GHSR-1a axis (related to GHRP-6's mechanism of action) suggested potential benefits in preeclampsia models, including improved placental remodeling and decidual macrophage reprogramming.

Evidence Limitations

The evidence base is notably limited by several factors:

All studies are preclinical (animal models only)
No human clinical trials have been completed or reported
Specific quantitative outcomes and biomarker values are not available in the published abstracts
Long-term safety and efficacy data are absent
Optimal dosing and administration routes remain unclear

Disclaimer: This information is for educational purposes only and should not be used as medical advice. Consult healthcare professionals before considering any therapeutic interventions.

GHRP-6

Member access required